Top Tech Companies (2,068)
Don't see your company?
Create a company profile
Parachute is a new kind of plasma donation company that allows individuals to earn money while creating life-saving medicine. Plasma is used to create medicine that treats chronic illnesses, including immune disorders, liver disease, bleeding disorders, and cancer. Right now, there’s a severe plasma shortage, which is impacting patients’ access to these life-saving treatments
Spark Therapeutics is focused on the development of gene therapy. At Spark Therapeutics, we don’t follow footsteps. We create the path. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is seemingly impossible to others, but not to us: Challenge the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now. Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm. Join us on a journey through uncharted territory – seeking to bring gene therapy for genetic diseases to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine for those with inherited diseases. Spark is a member of the Roche Group. Know that working at Spark Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world free of genetic disease.
At Freedom Plasma, we are on a mission to make it possible for thousands of patients around the globe to live happier, healthier lives as they struggle with serious autoimmune disorders and rare diseases. Plasma donations are essential to the creation of plasma-derived therapies used to treat these disorders. We believe that our incredible donors are heroes and we're always looking for new donor heroes to join us on this mission to save lives. Plasma donors are rewarded for the time they take to donate their life-impacting plasma. Each of our Freedom Plasma donation centers is dedicated to safe collection and procurement of blood plasma adhering to the highest standards of quality. Freedom Plasma is owned and operated by ImmunoTek Bio Centers, a leading-edge company within the plasma collection industry. We strive to provide unsurpassed care and service to enhance the lives of our employees, donors, and patients through the safe collection of quality plasma.
Help us shape the future of sports medicine! Breg provides premium, high-value sports medicine products and services that advance orthopedic patient care. From pioneering cold therapy products and innovative bracing to caring customer service and award-winning orthopedic practice solutions, Breg delivers a 360°customer experience unmatched in the industry. Breg is a company of Water Street Healthcare Partners. Founded in 1989, Breg offers cold therapy, knee, shoulder, spine, elbow/wrist, foot/ankle bracing and orthopedic practice solutions. The Company’s products are sold through more than 100 distributors in 36 countries. Breg is based in Carlsbad, CA. For two decades, Breg has transformed orthopedic care with industry-leading products. Breg is the leader in motorized cold therapy, selling over two million Polar Care® units. The Fusion® family of functional knee braces combine sleek, lightweight design with exceptional comfort and fit. Breg's SlingShot® 3 Shoulder Brace is the industry's first brace that off-loads pressure from the neck, greatly improving patient comfort. The Freestyle™ OA is the world's first wrap-around knee brace for osteoarthritis. Breg's newest products include the T Scope® Premier Knee brace and the T Scope Premier Hip brace which use Breg's easy-to-use hinge technology to manage patient mobility while maintaining patient comfort.
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
ImmuneSensor Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system. Based on groundbreaking discoveries from the research of the 2019 Breakthrough Prize awardee, Dr. Zhijian “James” Chen, we are pioneering a differentiated approach to both STING activators to boost anticancer immunity and cGAS inhibitors to suppress autoimmunity when the immune system is overactive.
OncoSec Medical, a biotechnology company, develops treatments for advanced stage skin cancer patients.
Harvestone Low Carbon Partners (HLCP) is a midwestern biofuels enterprise that owns Blue Flint, a 73 million gallon per year biorefinery in operation since 2007 near Underwood, North Dakota; Dakota Spirit, a 75 million gallon per year biorefinery in operation since 2015 near Spiritwood, North Dakota; and Iroquois Bio Energy Company, a 50 million per year biorefinery in operation since 2007 at Rensselaer, Indiana. Together, with our partners, we are building a renewable energy future for our country, creating value for local producers, and bringing prosperity to our communities. Together with our partners, we are building a renewable energy future for the country, increasing value for North Dakota farmers, and bringing prosperity to our communities.
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT) set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next generation immunotherapeutics.
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology, Microglassification™, produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for incorporation into drug delivery formulations such as suspensions(for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
BioTuring deliver important algorithms and software to tackle biomedical challenges.
Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.
Anatomi is advancing the fundamental understanding of neurodevelopment and genuine human neural networks.
Innovative Genetics is a pioneer in its segment of the biotechnology industry.
Erimos Pharmaceuticals is a biopharmaceutical company
Brinkbit is a fast, extensible, and scalable BaaS platform for game services, content management, live ops, and more!
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
AI to Diagnose Disease From Pathology Images
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment
